New insulin method aims to protect kidneys in diabetes patients

NCT ID NCT07187479

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times

Summary

This study tests a method called physiologic insulin resensitization (PIR) to see if it can improve kidney function in people with advanced chronic kidney disease and type 2 diabetes. About 120 adults will either receive PIR or standard care. Researchers will measure kidney health markers like eGFR and urine protein levels over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Arizona Kidney Disease and Hypertension Center

    RECRUITING

    Phoenix, Arizona, 85027, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.